Overall, RAR, as a combined indicator of RDW and albumin, may more sensitively capture the inflammatory status, nutritional condition, and liver function changes in patients with HBV-HCC, thus providing a more accurate prediction of their prognosis. The gene discussed is ALB; the disease is hepatocellular carcinoma.